Long-term Extension Study of Ligelizumab in Food Allergy
Condition: Food Allergy Interventions: Drug: Ligelizumab 120 mg; Drug: Ligelizumab 240 mg Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials